EGFR Positive Non Small Cell Lung Cancer Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Active, not recruiting
- Advanced Solid Tumors
- +4 more
- Phoenix, Arizona
- +15 more
2022-04-04
Apr 4, 2022N
Active, not recruiting
- EGFR Positive Non-small Cell Lung Cancer
- Erlotinib plus Bevacizumab
- Erlotinib
- Goyang-Si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
2022-04-04
Apr 4, 2022A
Recruiting
- EGFR Positive Non-small Cell Lung Cancer
- APG-1252
- Osimertinib Mesylate Tablets
- Guangzhou, Guangdong, China
- +3 more
2021-10-27
Oct 27, 2021N
Recruiting
- NSCLC Stage IIIB
- +4 more
- Hong Kong, Hong Kong
- +8 more
2021-09-20
Sep 20, 2021N
Recruiting
- EGFR Positive Non-small Cell Lung Cancer
- Non Small Cell Lung Cancer
- Singapore, SingaporeNational University Hospital
2021-08-31
Aug 31, 2021K
Active, not recruiting
- EGFR Positive Non-small Cell Lung Cancer
- Anyang, Gyeonggi-do, Korea, Republic of
- +7 more
2021-07-13
Jul 13, 2021M
Not yet recruiting
- Stage IV Non-small Cell Lung Cancer
- +7 more
- POISE
- Boston, MassachusettsMassachusetts General Hospital
2021-05-20
May 20, 2021F
Not yet recruiting
- EGFR Positive Non-small Cell Lung Cancer
- Brain Metastases
- Hangzhou, Zhejiang, ChinaHangzhou Cancer Hospital
2020-11-19
Nov 19, 2020T
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Heidelberg, GermanyThoraxklinik-Heidelberg gGmbH - Universitätsklinikum Heidelberg
2020-03-09
Mar 9, 2020B
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
- Icotinib
- Placebo
- Beijing, Beijing, China
- +10 more
2018-07-12
Jul 12, 2018B
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
- Beijing, Beijing, ChinaChinese People's Liberation Army (PLA) General Hospital
2017-02-07
Feb 7, 2017F
Not yet recruiting
- Lung Adenocarcinoma
- EGFR Positive Non-small Cell Lung Cancer
- EGFR-TKI
- Thoracic Hypofractionated Radiotherapy
- (no location specified)
2016-05-26
May 26, 2016B
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
- Sequential Icotinib Plus Chemotherapy
- Icotinib
- Lanzhou, Gansu, China
- +30 more
2015-04-27
Apr 27, 2015B
Unknown status
- EGFR Positive Non-small Cell Lung Cancer
- Adenocarcinoma
- Sequential and maintenance icotinib
- Maintenance icotinib
- NanNing, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
2014-07-17
Jul 17, 2014